Survey shows US warning letter trend against Europeans
This article was originally published in Clinica
Executive Summary
European manufacturers receive a disproportionate number of warning letters from US FDA inspectors, an inequity that is creating "significant barriers" for companies wanting to export to the US, says a new study by the FDA's former head of device compliance.